Brett A. Wall
CIK 1473812 · EVP & Pres Neuroscience · last filed 2026-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.59M
Companies
2
Total Filings
31
Lifetime Open-Market Net
-$2.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDT | EVP & Pres Neuroscience | 82,183 | $80.20 | $6.59M | -$2.91M | 26 | 2026-05-28 |
| ev3 Inc. (EVVV) Delisted | Sr. VP, Pres. Int'l Division | 64,762 | — | — | -$33.8K | 5 | 2010-07-13 |
Recent Filings · Page 2 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-12 | MDT | Tax (F) | −435 | -$34.5K | EDGAR |
| 2023-08-16 | MDT | Sell (S) | −1,000 | -$83.4K | EDGAR |
| 2023-08-07 | MDT | Mixed | +884 | -$362.0K | EDGAR |
| 2023-08-02 | MDT | Mixed | +9,686 | $0 | EDGAR |
| 2023-07-18 | MDT | Sell (S) | −2,000 | -$175.9K | EDGAR |
| 2022-12-09 | MDT | Tax (F) | −337 | -$26.6K | EDGAR |
| 2022-08-03 | MDT | Grant (A) | +7,521 | $0 | EDGAR |
| 2022-08-02 | MDT | Disp (D) | −7,493 | $0 | EDGAR |
| 2021-11-09 | MDT | Tax (F) | −238 | -$29.3K | EDGAR |
| 2021-08-04 | MDT | Mixed | +3,851 | -$194.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.